Residents

Actavalon, Inc.

Actavalon, Inc.

Actavalon is developing small molecule therapeutics capable of restoring p53 tumor suppression activity lost in human cancer cells.

Area of focus: 
Oncology
Commencement date: 
09/15/2016

Contact

Share